Corcept Therapeutics rose 40.0% in a year. Merck rose 72.1%.

Same industry

CORT against four drug peers, a year at 100

CORT is up 40.0% in a year. Merck is up 72.1% and Eli Lilly 56.6%. Of these four, Johnson & Johnson (+32.3%) and AbbVie (+24.3%) did less. Weekly closes, Oct 17, 2025 = 100, on a log scale, so the same percentage move is the same height on every line.

Share this chart

CORT +40.0%. Merck +72.1%, Eli Lilly +56.6%, Johnson & Johnson +32.3%, AbbVie +24.3%. Weekly closes, Oct 17, 2025 = 100, log scale.

Share this chart

End-of-day closes (Databento EOD), the last close of each week. The four peers are the largest US-listed companies by market value in CORT’s SEC industry (Pharmaceutical Preparations) with a year of closes. It shows what the closes did; a move here is not a cause, a forecast or a call.

CORT: stories, the record and filings →